Follow
Swarna Bale
Swarna Bale
Post Doctoral Research Fellow, Brigham and Women's Hospital, Harvard Medical School, Boston
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
V Pooladanda, S Thatikonda, S Bale, B Pattnaik, DK Sigalapalli, ...
Cell death & disease 10 (2), 81, 2019
1112019
Overview on therapeutic applications of microparticulate drug delivery systems
S Bale, A Khurana, ASS Reddy, M Singh, C Godugu
Critical Reviews™ in Therapeutic Drug Carrier Systems 33 (4), 2016
1002016
An adaptogen: Withaferin A ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines
S Bale, P Venkatesh, M Sunkoju, C Godugu
Frontiers in pharmacology 9, 319296, 2018
662018
Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs
D Ravikumar Reddy, A Khurana, S Bale, R Ravirala, ...
SpringerPlus 5, 1-9, 2016
592016
Synthesis of 1, 2, 4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents
R Tokala, S Bale, IP Janrao, A Vennela, NP Kumar, KR Senwar, ...
Bioorganic & medicinal chemistry letters 28 (10), 1919-1924, 2018
562018
Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases
G Pulivendala, S Bale, C Godugu
Drug delivery and translational research 10 (2), 339-353, 2020
392020
A facile I 2-catalyzed synthesis of imidazo [1, 2-a] pyridines via sp 3 C–H functionalization of azaarenes and evaluation of anticancer activity
GS Mani, SP Shaik, Y Tangella, S Bale, C Godugu, A Kamal
Organic & Biomolecular Chemistry 15 (32), 6780-6791, 2017
392017
Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo
G Pulivendala, S Bale, C Godugu
Toxicology and Applied Pharmacology 391, 114913, 2020
382020
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis
B Shi, W Wang, B Korman, L Kai, Q Wang, J Wei, S Bale, RG Marangoni, ...
Iscience 24 (1), 2021
362021
Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug …
R Boyapally, G Pulivendala, S Bale, C Godugu
Life sciences 220, 8-20, 2019
362019
The role of plant‐derived products in pancreatitis: experimental and clinical evidence
P Anchi, A Khurana, S Bale, C Godugu
Phytotherapy Research 31 (4), 591-623, 2017
362017
Withaferin A, a novel compound of Indian ginseng (Withania somnifera), ameliorates Cerulein‐induced acute pancreatitis: Possible role of oxidative stress and …
VL Tiruveedi, S Bale, A Khurana, C Godugu
Phytotherapy research 32 (12), 2586-2596, 2018
332018
Withaferin A attenuates bleomycin‐induced scleroderma by targeting FoxO3a and NF‐κβ signaling: Connecting fibrosis and inflammation
S Bale, G Pulivendala, C Godugu
Biofactors 44 (6), 507-517, 2018
302018
Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-β1 driven epithelial-to-mesenchymal transition
MP Goud, S Bale, G Pulivendala, C Godugu
International immunopharmacology 75, 105755, 2019
262019
Tankyrase as a novel molecular target in cancer and fibrotic diseases
T Vijaya Lakshmi, S Bale, A Khurana, C Godugu
Current drug targets 18 (10), 1214-1224, 2017
232017
Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice
S Bale, M Sunkoju, SS Reddy, V Swamy, C Godugu
Indian journal of pharmacology 48 (6), 643-648, 2016
232016
Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma
S Diddi, S Bale, G Pulivendala, C Godugu
Inflammopharmacology 27, 139-149, 2019
212019
Protective effects of nanoceria in imiquimod induced psoriasis by inhibiting the inflammatory responses
A Domala, S Bale, C Godugu
Nanomedicine 15 (1), 5-22, 2020
172020
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis
D Xu, S Bhattacharyya, W Wang, I Ifergan, MYAC Wong, D Procissi, ...
JCI insight 7 (5), 2022
92022
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
W Wang, S Bale, J Wei, B Yalavarthi, D Bhattacharyya, JJ Yan, ...
Nature communications 13 (1), 6358, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20